Wednesday 20th April, 9:00 to 18:30
Møller Centre, Churchill College, Storey's Way, Cambridge CB3 0DE
This one day conference will focus on issues surrounding the decision to invest in commercialisation of early stage technology, and evaluation of the factors which can be assessed to maximise the chance of a successful outcome. The topics to be discussed are:
- Health economics (Dr. Stuart Hendry, HecoAnalytics)
- Patent due diligence (Dr. Gareth Williams, Marks & Clerk)
- Competitive analysis (Bruce Chin, FULD+)
- Financial valuation (Dr. Michael Brand, Captum Capital)
- Decsion making under uncertainty (Dr. Chris Brand, Birkbeck College London)
Who Should Attend:
This Conference will be of value to everyone who has the responsibility for evaluating new technology from a strategic perspective: innovation and R&D managers; technology transfer executives; CEOs, COOs, and CTOs of early stage technology companies; strategy and technology managers in large corporates; licensing executives; professional advisors to technology based businesses.
Early registration is advised. The registration fee includes all conference materials, lunch and refreshments, and an evening networking reception.
The conference provides an exceptional opportunity to interact with leading experts experienced in the evaluation of early stage technology during the day, at the panel discussion, and at the networking reception. Discussions will be at an introductory to intermediate level which will benefit those with little exxposure to evaluation issues as well as those with more expertise.
_____________________________________________